Shared on 17 Oct 25Analysts have made a slight downward adjustment to Nuix's price target, now set at $3.51. This reflects a marginal decrease in the company's discount rate as they fine-tune their assessment of market conditions.Read more0 votesShareShared on 03 Oct 25Fair value Increased 6.00%Nuix's analyst price target has increased from $3.31 to $3.51. This change reflects analysts' improved outlook on the company's revenue growth and profit margins.Read more0 votesShareShared on 26 Aug 25Fair value Decreased 14%The downward revision in Nuix’s price target primarily reflects reduced consensus estimates for both revenue growth and net profit margin, resulting in the fair value decreasing from A$3.86 to A$3.45. Valuation Changes Summary of Valuation Changes for Nuix The Consensus Analyst Price Target has significantly fallen from A$3.86 to A$3.45.Read more0 votesShareShared on 01 May 25Fair value Decreased 26%Read more0 votesShareShared on 23 Apr 25AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 17 Apr 25AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 09 Apr 25Fair value Decreased 7.92%AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 02 Apr 25AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 26 Mar 25Fair value Decreased 1.56%AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 19 Mar 25Fair value Decreased 2.53%AnalystConsensusTarget made no meaningful changes to valuation assumptions.Read more0 votesShareShared on 13 Mar 25Fair value Increased 44%AnalystConsensusTarget has increased revenue growth from 14.1% to 18.0%, increased future PE multiple from 30.0x to 41.1x and decreased shares outstanding growth rate from 0.0% to 0.0%.Read more0 votesShare